Back
Meta Platforms Vs. Akero Therapeutics Industry Stock Comparison
Buy
66
META
Meta Platforms
Last Price:
$733.66
Seasonality Move:
8.16%
Buy
60
AKRO
Akero Therapeutics
Last Price:
$56.25
Seasonality Move:
34.97%
Buy
66
Meta Platforms (META)
is a Buy
Is Meta Platforms a Buy, Sell or Hold?
-
The current Meta Platforms [META] share price is $733.63. The Score for META is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
META is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $56.19. The Score for AKRO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
META Stock Price Chart
What is Meta Platforms's stock price today?
-
The Meta Platforms share price today is $733.63Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and META is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $56.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
META Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 22.54 | Buy |
| Relative Strength Index (14 RSI): | 70.75 | Buy |
| Chaikin Money Flow: | 11712763 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (655.03 - 710.85) | Buy |
| Bollinger Bands (100): | (563.79 - 695.27) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.45 | Buy |
| Relative Strength Index (14 RSI): | 67.53 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.33 - 55.87) | Buy |
| Bollinger Bands (100): | (40.08 - 52.38) | Buy |
META Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 706.81 | Buy |
| 20-day SMA: | 693.95 | Buy |
| 50-day SMA: | 632.23 | Buy |
| 200-day SMA: | 610.24 | Buy |
| 8-day EMA: | 711.5 | Buy |
| 20-day EMA: | 691.4 | Buy |
| 50-day EMA: | 655.47 | Buy |
| 200-day EMA: | 600.51 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55 | Buy |
| 20-day SMA: | 54.01 | Buy |
| 50-day SMA: | 47.06 | Buy |
| 200-day SMA: | 38.07 | Buy |
| 8-day EMA: | 55.12 | Buy |
| 20-day EMA: | 53.19 | Buy |
| 50-day EMA: | 48.99 | Buy |
| 200-day EMA: | 39.98 | Buy |
Meta Platforms Earnings Growth & META Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.59 per share, an increase next quarter of $0.44 per share, an increase this year of $2.89 per share, and an increase next year of $2.99 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Meta Platforms Technical Analysis
| Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||